πŸ‡ΊπŸ‡Έ FDA
Patent

US 10945972

Particulate materials

granted A61KA61K31/137A61K31/48

Quick answer

US patent 10945972 (Particulate materials) held by Nektar Therapeutics expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Mar 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/137, A61K31/48, A61K31/485, A61K31/4985